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EFFECTS OF ENVIRONMENTAL HEAVY METALS ON NEURAL STEM
CELL SURVIVAL AND DIFFERENTIATION
SAMEERA TASNEEM
ABSTRACT

Heavy metals are usually found in the environment (air, water, land, food chains), but
their concentrations have been increasing due to increased industrialization and improper
waste disposal. Many heavy metals have been characterized for their toxic effects,
including developmental toxicity, mental retardation, neurological impairment such as
blindness,

neuromuscular

weakness,

altered

neurobehavioral

development,

neurocognitive deficits and many other related disorders, in both human beings and
animals. In this study, we seek to understand the specific effects of cadmium, mercury
and lead on neural stem cell (NSC) survival and differentiation, to gain further insight on
their toxic effects during embryogenesis. NSCs are self-renewing, multi-potent resident
brain cells, which differentiate into various neural and glial lineages depending on the
spatial-temporal cues and signaling molecules they receive. Here we investigated the
effects of cadmium, lead and mercury on embryonic rat NSC differentiation and neurite
outgrowth in a 3D environment over a 14 day culture period. Type I collagen was used to
create an extracellular 3D microenvironment for NSC culture, and various concentrations
(0.01 nM – 10 µM) of metal ions were added. NSC survival, differentiation and neurite
outgrowth into various neural and glial lineages was assessed both qualitatively and
quantitatively, at various time points. Results suggest the tremendous adverse impact
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metal ions could exert, even at as low as 0.1 nM concentration, on the initiation and
propagation of neurological deficits in the developing central nervous system.
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CHAPTER I
INTRODUCTION
Heavy metals are defined as the metals having density greater than 5 g/cm3[1].
Some of them such as iron, copper, selenium, and zinc are essential for normal
metabolism. But, many heavy metals such as lead, mercury and cadmium are toxic even
in minute concentrations. They naturally exist in the earth’s crust and are emitted during
activities like volcanic eruptions, erosions, etc. Growth of industrialization in the past few
decades and activities such as mining, combustion of fossil fuels, improper disposal of
batteries, paints and industrial wastes containing heavy metals, usage of phosphate
fertilizers and sewage sludge for cultivation of crops have led to an increase in the
concentration of toxic heavy metals in the environment. These increased concentrations
are posing many health issues either directly or indirectly. Federal bodies, such as the
World Health Organization (WHO), The Environmental Protection Agency (EPA), and
The Food and Drug Administration (FDA), are making constant efforts to minimize these
emissions into the atmosphere. There are many places where concentrations of these
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heavy metals are beyond allowable limits. Studies have shown that most of these affected
places are located in under-developed countries. Reports from some recent studies
implicate that these metals cause toxicity even at concentrations lower than the standard
limits set by federal agencies.
In this study, we chose to investigate the effects of cadmium, mercury and lead, as
these are some of the most hazardous heavy metals. These metals are known for their
systemic toxic effects causing damage to the organs such as nervous, cardiovascular,
reproductive, renal, digestive and the endocrine systems[2]. Most common occurrence of
heavy metal toxicity is due to occupational exposure, contaminated food and water. As
these metals are non-degradable, they bio-accumulate through food chains. A very
sensitive case of toxicity is developmental toxicity which occurs due to exposure to these
metals during pregnancy. Much research has been done on the causes of developmental
disorders by using different kinds of animal and cellular models. Developing nervous
system of fetus is reported to be the major site of action of these metals

[1,4,5,6].

Our long-

term goal is to study the toxic effects of cadmium, mercury and lead on the development
of nervous system during embryogenesis. Rat neural stem cells were used in our study as
they are the precursor cells to various neural cell lineages which constitute the nervous
system.
The stem cells were exposed to various concentrations of heavy metals for
different culture periods. Determining the viability of cells under given conditions was
the initial aim in our study. The second aim was to observe morphology and neurite
outgrowth at the chosen concentrations, and to compare them with respective control
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group at different exposure times. Finally, we determined the effects of these metal ions
on neural stem cell differentiation into broad neural and glial (astrocytes,
oligodendrocytes) lineages using immune-fluorescence staining for specific markers.
Chapter-II discusses the sources of metal toxicity, systemic toxic effects,
mechanism of toxicity of the metals, characteristics of neural stem cells, its lineages and
specific markers. This chapter also has a brief description about previous toxicity studies.
Chapter-III details the materials and methods used in this study, including
preparation of the 3D scaffolding, cell culture conditions, the protocols used for
Immunofluorescence staining and quantification of data.
Chapter-IV provides the results obtained from our proposed studies and discusses
our data in context to that reported in literature. Finally, chapter-V consolidates the
conclusions from our results obtained in this study and provides a roadmap for future
studies in this area of research.
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CHAPTER II
BACKGROUND

Cadmium, mercury and lead are among the top 10 hazardous agents in the
substance priority list of 2011, prepared by the United States Environmental Protection
Agency EPA and the Agency for Toxic Substances and Disease Registry (ATSDR) [3]. All
humans come across these metals in their daily lives, as they are natural constituents of
the environment. There has been a rapid increase in the production, usage and emission
of these heavy metals since the beginning of the 19thcentury, coinciding with the western
industrial revolution [1]. The issues concerned with heavy metal pollution are continuously
reviewed by federal agencies such as the EPA, the ATSDR and the World Health
Organization (WHO) [1].Although considerable progress has been made with regard to
their monitoring and regulation, leading to the decrease in the release of these toxic
metals, their concentrations still exceed the allowable limits in many regions of the world
[1].

Such an increase in environmental heavy metal concentration poses an alarming

concern towards their negative impact on human health.
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The U.S. Department of Health and Human Services (DHHS) and the
International Agency for Research on Cancer (IARC) and the EPA state that cadmium,
mercury and lead are carcinogenic beyond allowable limits, and cause developmental
toxicity causing birth defects in newborns[4,5,6].Their systemic toxic effects have been
studied extensively in animals, occupationally exposed workers and in exposed children[
4, 5,6].

It has been noted that children, infants and the developing embryos are at a higher

risk to toxic effects than adults, as their physiology and defense mechanisms are less
developed

[1,4,5,6,7].

In general, they affect most of the organs in human body, but the

nervous system was found to be the most sensitive target

[1, 7].

The common neuro-

developmental toxic effects caused by cadmium, mercury and lead include altered neurobehavioral development, neurocognitive deficits, mental retardation, muscular weakness,
poor co-ordination of motor and sensory responses and teratogenic effects[7].These
elements could easily penetrate the blood-brain-barrier (BBB) and enter the brain
extracellular environment, or taken up by the cells lining the BBB. Lot of research has
been done in the past to study their various toxic effects, mechanisms and factors
involved. Some of the basic information about them is discussed in the following
sections.
2.1. Cadmium
Cadmium is a heavy metal found associated with other metals such as copper,
zinc and lead in ores [4]. It is released into soil, water and air due to mining and refining of
non-ferrous metal ores, combustion of fossil fuels, manufacturing and application
phosphate fertilizers, waste incineration (combustion of cadmium containing substances
and batteries) and their disposal along with the domestic waste[1,3,7].Cadmium
5

accumulates in plants and marine organisms due to improper disposal into soil and
aquatic ecosystems respectively [4,8].
Highest usage of cadmium (83%) occurs in nickel-cadmium battery production
facilities followed by industries producing pigments (8%), coatings and plating (7%),
stabilizers for plastics (1.2%) and others (0.8%)[4]. People working at these industries can
be at risk of cadmium toxicity[4, 8]. There are strict federal regulations concerned with
disposal of industrial wastes containing cadmium which require the wastes to undergo
necessary treatments in order to convert toxic forms of the metal into non-toxic ones.
According to the EPA, cadmium concentration for natural surface water and ground
water is <1 µg/L. But, in water sources near cadmium industries both in current operation
and in the past, there is a marked elevation to more than 70 µg/L[4].
The major concern with cadmium is its non-degradable nature, due to which it
stays in the environment forever[4, 8]. Cadmium exists in different forms such as oxide,
chloride or sulfate, gets transported long distances by wind, and is subsequently deposited
in soil or water resource[4]. The heavy metal when taken up by marine organisms, plants,
animals, and water resources will be carried over to human beings[4, 8, 10]. Tobacco leaves
are known to accumulate the highest levels of cadmium[4]. According to ATSDR, national
average blood cadmium level for adults is 0.38 µg/L, whereas for New York City
smokers it is 1.58 µg/L (more than 4-fold)[4]. The amount of cadmium absorption from
one pack of cigarette is nearly 1-3 µg[4,8, 10].For non-smokers, cadmium contaminated
food, water, air or inhalation are the major sources of exposure and the average cadmium
intake through food is in between 8 and 25 µg per day[7,8,10].
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About 5-50% of inhaled cadmium is absorbed through the lungs[4]. The chance of
absorption of cadmium through gastro intestinal tract increases if the diet is deficient in
iron and also during pregnancy (because of iron deficiency)[4, 7, 10, 12, 13]. Absorption of
cadmium through skin is not reported[4]. Cadmium toxicity mostly affects kidneys and
bones[4, 8, 10]. It also affects reproductive, hepatic, immune and hematological functions[4].
Inhalation of high levels of cadmium in humans can cause severe lung damage and
death[4]. Inhaling low levels of cadmium over long periods (years), and ingestion results
in accumulation in kidneys and bones[4]. In later ages these long term exposures can result
in end-stage renal disease, worsens the diabetic effects on renal system and demineralizes the bones

[4, 8, 10].

It is reported to be involved in prostrate, breast, pancreatic

and other type of cancers[4, 8, 10]. It also contributes to motor neuron disease and other
nervous system disorders. Evidence also shows that it has a role in neuro-degenerative
diseases such as Parkinson and Alzheimer’s disease. Further information on the
neurotoxic effects of cadmium needs to be investigated [4, 8, 10, 11].
Children absorb more amounts of cadmium than adults and therefore experience
higher body burden and toxic effects[7]. Cadmium is capable of passing through the
placenta, and thus could affect the fetus in early developmental stages[12,

13].

Animal

studies have shown that exposure to high levels of cadmium during pregnancy results in
harmful effects in the new born, such as reduced head size with unclear boundaries in
brain[4]. Nervous system is a sensitive target in developing embryos and damage to
neurons and glial cells have been reported in the developmental toxicity studies[4]. It
might contribute to hyperactivity, attention deficits and mental disorders in children

[4, 7].

It also affects the birth weight and development of skeleton in the fetus[4,14]. Under some
7

conditions such as pregnancy, lactation, old age and in certain diseases, there are high
chances that the accumulated heavy metal may re-enter the systemic circulation [12, 13].
Cadmium increases the oxidative stress in neural cells by acting as a catalyst in
the formation of reactive oxygen species, and increases lipid peroxidation [4,11]. It depletes
anti-oxidant enzymes such as glutathione peroxidase and superoxide dismutase and
sulfhydryl groups on various proteins[4]. It replaces the calcium, zinc, iron, copper and
selenium ions which are involved in cellular metabolic pathways [4, 11].
2.2 Mercury
Mercury naturally exists as metallic mercury in coal and gold ores, mercuric
sulfide (cinnabar ore), mercury chloride and methyl mercury[5,1]. It is broadly categorized
as metallic mercury, and also called as elemental mercury, inorganic mercury and organic
mercury[1,5]. Metallic mercury exists as a liquid at room temperature, and elevation in
temperature causes an increase in the release of vapors from the liquid mercury[5].
Inorganic forms of mercury are chloride, sulfate and oxides forms of the metal[1,5]. When
mercury combines with carbon it is called organic mercury[1,5]. Many micro-organisms
can convert elemental and inorganic mercury into organic forms which are highly
potent[1,5].
Mercury is used in the production of chlorine gas, caustic soda, thermometers,
barometers, batteries, fluorescent light bulbs and electrical switches[1,5]. According to the
ATSDR, 80% of mercury emissions into the air in vapor form are primarily due to fossil
fuel (coal) combustion, production of cement, mining, smelting and solid waste
incineration[1,5]. These vapors can condense and deposit over soil, water, and other
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substances which may come in contact with it[1,5]. Fertilizers, fungicides, municipal solid
waste contribute about 15% of pollution and 5% is from contamination of natural water
resources by industrial waste water[5].

Figure 2.1 Schematic diagram showing bio-accumulation of mercury[22].
In some places of Latin America and Asia, mercury is used to treat several
ailments. For example, mercury chloride is used in topical agents as an antiseptic agent[1].
Mercuric sulphide and oxide are used in paints and tattoo dyes[5]. Inorganic mercury
forms have been used in cosmetic products, laxatives, teething powders and worming
medications[1]. As toxic effects of mercury became more evident, the heavy metal is being
refrained from use in some of these medications[1]. But Thiomersal, a phenyl mercuric
nitrate, is still being used as a preservative in some medications[17]. Until recently, dental
amalgams contained nearly 50% metallic mercury and release nearly 3-17 g mercury
9

per day, depending on the number of dental fillings[5, 16]. According to The FDA, most
people of average weight are exposed to 3.5 µg of mercury per day[5].
Potential sources of mercury exposure are inhalation, ingestion of contaminated
water and food, dermal contact, dental amalgams, accidental spillage from batteries,
thermometers, switches and other appliances[1,5]. Nearly 80% of inhaled mercury is
absorbed into the systemic circulation which rapidly enters the vital organs and remains
there for years[1,5]. As a consequence of this accumulation, the heavy metal is reported to
cause systemic toxic effects[1,5]. Acute exposure to high concentrations can be lethal and
at chronic exposure level brain and kidney damage are more prominent[5].
Mercury can affect many different areas of brain and their functions resulting in
impaired learning and cognitive abilities, vision, hearing, muscle coordination, memory
in children[5,15]. Many children were affected by Acrodynia in the past due to usage of
teething powder containing mercury[5,15]. Mercury passes to developing embryo through
placenta during gestation period from affected mother and could cause birth defects [5, 12,
13, 15, 16].

Infants can be exposed to mercury during lactation if the mother has been

previously exposed to the heavy metal. According to a recent study, mercury exposure
through dental amalgam in pregnant women and use of vaccines containing thiomersal
has increased prevalence of autism in children. [12, 13, 14]
The major mechanism of toxicity is due to binding of the heavy metal to the
sulfhydryl groups of proteins. These proteins are mainly present in extra and intracellular
membranes and organelles[5]. By targeting these proteins, mercury inactivates various
enzymes, alters structural proteins, ceases transport processes and imposes changes in
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cell permeability[5]. Binding of mercury to amino and carboxylic groups is also observed
to be a mechanism of toxicity[5].Mercury increases oxidative stress, obstructs microtubule
formation, interferes in cellular activities such as DNA replication, protein synthesis,
calcium homoeostasis, and synaptic transmission. These effects may occur individually
or in combination[5].
2.3 Lead
Lead is a bluish-gray metal naturally existing in the earth’s crust in different
ores[6]. Lead is resistant to corrosion when exposed to air and water[6]. It has been found in
toxic concentrations at ~1272 NPL listed sites[6]. Many other places still need to be
investigated for the occurrence of lead. It is used in manufacturing of pipes, storage
batteries, weights, bullets and ammunition materials, cable covers and sheets used for
protection from radiation[1,6]. The highest usage of lead is in the production of batteries
for automobiles[6]. It is also used in the production of ceramics, paints and dyes[6]. For
years lead was used as a constituent in gasoline before it was banned in 1996 [1,6]. Lead
emissions in the United States during 1979 were estimated to be 94.6 million kilograms
into the air[6]. Though the use of lead has been banned in many applications, being a nondegradable metal it still exists in the atmosphere.[1,6].The secondary source for lead
emissions is due to paints containing lead[1,6]. Withering and chipping of lead based paints
from old houses and building is also the source of lead release to the soil[6]. Lead particles
can travel in air and settle on soils, surface waters and crops[1,6].
Over the last three centuries, environmental levels of lead have increased by
1000-fold due to human activity[6]. The major way to lead exposure is due to inhalation
and swallowing dust near roadways, older houses, old orchards where lead containing
11

pesticides were used, power plants, landfills, incinerators and hazardous waste sites[1,6].
The secondary sources are contaminated food, air and water[1,6]. Cigarette smoke can also
contribute to the lead exposure[6]. Pipes made of lead or the fittings and soldering made
with the metal in water lines can release toxic amounts of lead into the water[6]. Soil
sediments in the water bodies may contain lead if the soil from contaminated areas is
washed into them[6].
Exposure to toxic levels causes lead encephalopathy in adults and children[6, 7, 19].
Although the toxic effects are systemic, nervous system is the sensitive of all organ
systems[6, 7, 18,19]. It causes elevation in blood pressure and anemia[6,7,18]. Large amounts of
lead is absorbed into the systemic circulation which further gets transported to vital
organs such as brain, kidneys, heart, liver and bones and accumulates[6]. Sometimes it can
re-enter the blood stream under some conditions like pregnancy, breast feeding, old age,
bone fracture and osteoporosis[6,12]. In pregnant woman high levels of exposure are
reported to cause abortion and adverse birth defects[6, 13].

12

Figure 2.2 Schematic presentations of multiple toxic effects of lead. [6]
Children are more vulnerable to the lead toxicity compared to adults[6, 7,19]. No
safe blood concentration has been reported in children. Lead toxicity affects the
developmental stages of fetus if the mother has higher concentrations of lead in her blood
stream[6,12,13]. Lead is capable of passing through placenta and is also secreted in the
breast milk[6,12,13]. Exposure during gestation can result in reduced head circumference,
low birth weight and other abnormalities[6]. Exposed children may suffer from kidney

13

damage, colitis, muscle weakness and brain damage which can be fatal[6,

7, 19].

It is

reported to cause intellectual deficits, poor learning abilities and retardation[6,7,19].
Lead affects the nervous system by mimicking the action of calcium ions
physiologically[6]. As calcium is involved in many signaling pathways it affects many
cellular functions[6]. One of the important groups of enzymes called protein kinase C
(PKC) is involved in many processes which play an important role in synaptic
transmission such as synthesis of neurotransmitters, ligand-receptor interactions,
conductance of ionic channels and dendritic branching[6]. The changes in PKC enzyme
causes decreased expression of glial fibrillary acidic protein (GFAP) specific for
astrocytes[6]. Astrocytes along with the endothelial cells form the blood brain barrier
which restrains most of the materials entering the brain[20,21]. Therefore, the permeability
of blood brain barrier is increased in the developed nervous system due to lead
exposure[6]. The γ-isoform of PKC family is a potential target by lead[6]. Most of this
enzyme is present in membrane bound vesicles in adult cells, but in developing stages
these enzymes occur in cytosol which makes fetus vulnerable to toxicity[6]. Lead
modulates the structure of another enzyme calmodulin which plays a key role in cAMP
messenger pathways[6]. Lead also substitutes for zinc and affects the enzymes and cellular
functions that depend on zinc as a co-factor[6]. This affect causes difference in the
expression of myelin basic protein in the nervous system which is specific for
oligodendrocytes[6]. These cells secrete myelin, which prevents the leakage of action
potential, coordinate the sensory and motor impulses. Lead disrupts neurotransmitters
systems especially cholinergic, dopaminergic and glutamatergicsystems[6]. Dopamine is
involved in cognitive functions of brain such as learning[6]. Acetylcholine is involved in
14

various processes including memory[6]. Lead toxicity on these systems is suggested to be
the possible reasons for mental retardation, can be a contributing factor for neurodegenerative diseases like Parkinson’s and Alzheimer’s disease.[6]
2.4. Neural stem cells
Neural stem cells are a class of self-renewing, multi-potent, neural progenitor
cells which have the capacity to differentiate into major types of neural and glial cells of
the central nervous system (CNS)

[21, 23]. Studies

show that the NSCs are more prevalent

at early stages of the formation of brain in embryo

[21, 23]. They

divide by symmetric and

asymmetric divisions to give rise to new NSCs at this stage. As the development progress
the NSCs decrease in number and get committed to restricted progenitor cells and
differentiated cells. They decline to significant low level at the end of gestation as the
formation of brain completes. Part of the remaining cells helps in further development of
nervous system after the birth and during childhood. They are also present in some parts
of adult brain such as neurogenic regions, sub-ventricular zone, hippocampus and spinal
cord[23]. Adult neural stem cells help in repairing the damage caused by injury or disease
conditions to limited extent[21].
The type of lineage they differentiate into is dependent on the growth factors and
signaling molecules[23]. Different concentrations of fibroblast growth factor (FGF), bone
morphogenetic proteins (BMP) and noggin regulate the cell proliferation and
differentiation from neural induction through adulthood. In early embryonic
neurogenesis, noggin inhibits BMP to allow the proliferation of NSCs to neurons, but in
later stages BMP regulates the differentiation and favors the formation of astrocytes. FGF
helps in proliferation of NSCs and formation of neurons at very low concentrations
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during early development but later it inhibits the differentiation. Changes in signaling
pathways can cause difference in the NSC behavior. The exact mechanisms and signaling
pathways of NSCs are still under investigation.

Figure 2.3 Schematic of NSC differentiation mechanisms [20].
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CHAPTER III
MATERIALS AND METHODS

3.1 Preparation of Neural Stem cell (NSC) Media
Two types of media were use, one media containing b-FGF (non-differentiating
NSC media) and the other without b-FGF (differentiating NSC media). To make 20 ml of
differentiating media, we used
 20 ml DMEM w/ Na-pyruvate (Gibco -cat # 10313-021)
 20 µl 100x L-glutamate (Gibco -cat # 15039-019)
 200µl 100x N2 Supplement (Gibco –cat#17502-048)
 400 µl 100x B27 Supplement (Gibco -cat # 17504-044)
 200 µl 100x NAC (N-acetyl cysteine) (Sigma A9165)
The final solution was sterile filtered using 0.02 µm filter. All the ingredients
remained the same within non-differentiating media, except the addition of 20 µL of
1000× (10 µg/ml) b-FGF (Gibco -cat # 13256-029) to maintain the cells undifferentiated
[31].
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3.2 Preparation of type I collagen solution
The collagen solution at 2 mg/ml concentration was prepared by using collagen
type-I (9.46 mg/ml; BD biosciences).To make 10 ml of collagen solution, 1 ml of PBS,
2.114 ml of collagen, 48.6 µl of 1N NaOH and 6.84 ml of DI water was used[32].
The solution was placed over ice throughout the experimental use.
3.3 Preparation of metal solutions
The 100 µM metal solutions (master batches) were prepared for each metal by
dissolving calculated amount of specific metal in water and lower concentrations
prepared by serial-dilution method.
3.3.1 Preparation of Cadmium Chloride (CdCl2) solution
A 0.01 M cadmium chloride solution was prepared by dissolving 183 mg of
cadmium chloride (anhydrous, 99.99%, Alfa aesar) in 100 ml of de-ionized sterile water.
A 1ml of 0.01M cadmium chloride solution was diluted to 100 ml resulting in 100 µM
solution, which was used as stock solution for further dilutions. The concentrations of 10
µM, 1 µM, 0.1 µM, 0.01 µM, 1 nM, 0.1 nM and 0.01 nM solutions were prepared by
serially diluting the stock solution with culture media.
3.3.2 Preparation of mercury chloride solution
A 0.01 M mercury chloride solution was prepared by dissolving 272 mg of
mercury (II) chloride (98+%, Alfa aesar) in 100 ml of de-ionized sterile water. A 1ml of
0.01 M mercury chloride solution was diluted to 100ml which gave 100 µM solution
which was used as stock solution for further dilutions. The concentrations of 10 µM, 1
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µM, 0.1 µM, 0.01 µM, 1 nM, 0.1 nM and 0.01 nM solutions were prepared by serially
diluting the stock solution with media
3.3.3 Preparation of Lead acetate solution
A 0.01 M lead acetate solution was prepared by dissolving 379 mg of lead (II)
acetate trihydrate (99%, Alfa aesar) in 100 ml of de-ionized sterile water.
Aliquot of 0.01 M lead acetate solution was diluted to 100 ml which gave 100 µM
solution which was used as stock solution for further dilutions. The concentrations of 10
µM. 1 µM, 0.1 µM, 0.01 µM, 1 nM, 0.1 nM and 0.01 nM solutions were prepared by
serially diluting the stock solution with media.
3.4 Culturing the rat neural stem cells
Embryonic rat neural stem cells were obtained from Neuracell, NY. The cells
were shipped in a cryovial, frozen on ice. The cells were thawed by immersing the vial in
37 °C water bath and transferred to a sterile 15ml tube. Four milliliters of pre-warmed
non differentiating NSC media was added drop-wise to the cell suspension, while rotating
the tube to ensure proper mixing. Then the suspension was centrifuged at 10.6×g for five
minutes[31]. The supernatant was removed and 4ml of pre-warmed non differentiating
NSC media was added to the cell pellet at the bottom of the tube[31].
The pellet was re-suspended by pipetting up and down gently with a micropipette.
The cell suspension was distributed equally into T-25 flasks, pre-coated with poly-Llysine (Sigma Aldrich)[31]. The cells were cultured for 4 to 5 days or until the formation
of neurospheres was noticed. Media was changed every day in order to provide a
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continuous non-differentiating environment (b-FGF).After this period cells were ready
for experimental use[31].
On the day of seeding, all the media from culture flasks was removed and 3 ml of
trypsin-EDTA was added to detach the cells from the surface[31]. It was allowed to act for
5 minutes, and we observed in the microscope to ensure cell detachment. The cell
suspension was transferred to a 15 ml tube and centrifuged at 10.6 g for 5 min. The
supernatant was removed and the pellet was suspended in 2 ml of differentiating media
(without b-FGF)[31].
3.5 Cell cultures
Cells were seeded within a 3D collagen matrix. In order to create a 3D matrix,
collagen-I solution 2 mg/ml was used. 30 µl of collagen-I solution was added to the wells
and was polymerized at room temperature for 30 minutes on an even surface. It was made
sure that the layer of collagen was thin enough to view the cells while imaging. Then
equal volumes of cell suspension were added on the top of collagen layer. Another 30 l
of collagen-I solution was added on top of the cells and was allowed to polymerize for 30
minutes. The media containing different concentrations of metals solutions were added
on top of the collagen layer within respective culture wells (n =3 wells per metal ion
concentration).
3.6 Phalloidin staining
We stained the cells with 488 phalloidin (Life Technologies) for measuring the
neurite outgrowth. The cells were cultured in 3D collagen matrix for various durations for
these experiments: 1, 4, 7 and 14 days. At the end of the culture period, the cells were
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fixed by removing the media from all the wells and washing 3 times with PBS [33].. Then,
3.7% Para-formaldehyde solution (PFA) was added and incubated for 10 minutes[33]. The
PFA solution was removed from the wells, and washed 3 times (5 minutes per wash) with
PBS. Then 0.1% triton X-100 was added and was allowed to act for 5 minutes[33].The
wells were washed three times with PBS and 1% bovine serum albumin (BSA) was
added to the wells and was allowed sit for 30 minutes[33].. BSA was removed, phalloidin
solution was added to the wells in the dark, and the well plate was mounted on the
microscope for observation after 30 minutes[33]. Images for neurite outgrowth at different
concentrations of different metals and controls were captured using Zeiss Axiovert A1
fluorescent microscope with a 40 objective. From the images the neurite outgrowth was
quantified using Image-J software.
3.7. Live-dead assay
A live/dead viability/ cytotoxicity kit was purchased from Molecular Probes. The
staining solution was prepared by adding 20 µl of 2mM EthD-I (component B) solution
to 10 ml of warm D-PBS[34].5 µl of supplied 4mMcalcein AM in DMSO (component A)
was added to the EthD-I solution and vortexed[34].. Media from all the wells was removed
and the wells were washed with PBS for 3 times allowing 5 minutes for each wash[34]..
Then the staining solution was directly added to the wells and allowed it to act for 30
minutes[34].. The wells were washed 3 times and then observations were made using the
Zeiss Axiovert A1 fluorescent microscope. The number of live and dead cells was
counted in the green and red channels respectively. Average number of cells and
percentage survival was determined accordingly.
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3.8. Immunofluorescence staining for TUJ1, GFAP and MBP2
3.8.1 TUJ1
It is a neuron-specific class III beta tubulin marker expressed by neurons[34].Antibeta III tubulin [EP1331Y,Abcam)] rabbit monoclonal antibody was used as a primary
antibody to stain for TUJ1[34].. Goat serum was used as a blocking agent to avoid
nonspecific binding[34].Goat anti rabbit IgG-FITC (Santa Cruz Biotechnology) was used
as a fluorescein secondary antibody[34]..
3.8.2 GFAP
GFAP is Glial fibrillary acidic protein, specific in astrocytes[34].. Anti-GFAP
rabbit polyclonal antibody (Abcam) was used as a primary antibody to stain for
GFAP[34].. Goat serum was used as a blocking agent and goat anti rabbit IgG-FITC (Santa
Cruz Biotechnology) was used as a fluorescein secondary antibody[34]..
3.8.3 MBP
Myelin basic protein (MBP) is expressed by oligodendrocytes[34].. Rat anti –
myelin basic protein monoclonal antibody (Abcam) was used as a primary antibody to
stain for oligodendrocytes[34].. Goat serum was used as the blocking agent to avoid nonspecific binding[34].. Goat anti-rat IgG –FITC (Santa-Cruz Biotechnology) was used as the
fluorescein secondary antibody[34]..
3.8.4 Primary staining
The cells were cultured for 7 and 14 days. At the end of the culture period, the
cells were fixed by removing the media from all the wells and washing 3 times with
PBS[34].. Then, 3.7% Para-formaldehyde solution (PFA) was added and incubated for 10
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minutes[34].. The PFA solution was removed from the wells, and washed 3 times (5
minutes per wash) with PBS. Then 0.1% triton X-100 was added and was allowed to act
for 5 minutes[34].. The wells were washed three times; blocking solution containing
0.1%triton X-100, 5% goat serum was added to the wells and incubated for 30
minutes[34].. The blocking solution was removed from the wells and the primary antibody
solution containing 0.1% triton X-100, 5% goat serum and primary antibody (1:100) was
added and stored at 4 °C overnight[34]..
3.8.5 Secondary staining
The next day primary antibody solution was removed from the wells and Washed
three times (10 minutes per was) with PBS. Secondary antibody solution was added
containing 0.1% triton X-100, 5% goat serum and secondary antibody (1:400) and
incubated for 30 minutes[34].. Then the wells were washed three times (10 minutes per
wash) with PBS. DAPI was added and observations were made using the Zeiss axiovert
A1 fluorescence microscope..
3.9 Immunofluorescence staining for HB9 and TH
3.9 .1 HB9
It is a specific marker expressed by motor neurons. Goat HB9 (H-20) antibody
(SC -22542), by Santa Cruz biotechnology was used as the primary antibody to stain for
motor neurons. Donkey serum was used as the blocking agent and donkey anti goat IgGFITC, (SC-2024), by Santa-Cruz biotechnology was used as the fluorescein secondary
antibody. The cells were cultured for day-7 and day-14 in different plates. At the end of
culture period, all the media from the wells was removed and the wells were washed with
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PBS for 2-3 times allowing 5-10 minutes for each wash. Then the cells were fixed using
ice cold 3.7% Para-formaldehyde solution for 10 minutes[35]. The wells were washed
with ice cold PBS 3 times for every 10 minutes to ensure all the Para- formaldehyde was
washed off[35]. Then the blocking solution was added containing 0.1% triton X-100 and
5% donkey serum and was soaked in it for 20-30 minutes[35] The blocking solution was
removed (washing was not required at this stage) followed by the addition of primary
antibody solution containing 0.1% triton X-100, 5% donkey serum, HB9 antibody
(1:100)[35]. The plate was stored at 4°C overnight. Next day the primary antibody solution
was removed and the wells were washed 3 times allowing 5-10 minutes of washing
time[35]. Then the secondary antibody solution was added containing 0.1% triton X-100,
5% donkey serum and donkey anti-goat IgG-FITC (1:400) (SC2024), by Santa Cruz
biotechnology and was allowed to act for 30 minutes[35]. The secondary antibody solution
was removed, the wells were washed 2-3 times, a drop of DAPI was added and
observations were made using Zeiss axiovert A1 Fluorescence microscope.
3.9.2 Immunofluorescence staining for TH
Tyrosine Hydroxylase (TH) is a specific marker expressed by Dopamine
producing neurons. Anti-TH (AB152, Millipore) was used as the primary antibody to
stain for motor neurons[35]. Goat serum was used as the blocking agent and goat anti
rabbit IgG-FITC (sc 2012) by Santa-Cruz biotechnology was used as the fluorescein
secondary antibody[35]. The cells were cultured for day-7 and day-14 in different plates.
At the end of culture period, all the media from the wells was removed and the wells
were washed with PBS for 2-3 times allowing 5-10 minutes for each wash[35]. Then the
cells were fixed using ice cold 3.7% para-formaldehyde solution for 10 minutes[35]. The
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wells were washed with ice cold PBS 3 times for every 10 minutes to ensure all the paraformaldehyde was washed off. Then the blocking solution was added containing 0.1%
triton X-100 and 5% goat serum and was soaked in it for 20-30 minutes[35]. The blocking
solution was removed (washing was not required at this stage) followed by the addition
of primary antibody solution containing 0.1% triton X-100, 5% goat serum, anti-TH
(1:100)[35]. The plate was stored at 4°C overnight. Next day, the primary antibody
solution was removed and the wells were washed 3 times allowing 5-10 minutes of
washing time[35]. Then the secondary antibody solution was added containing 0.1% triton
X-100, 5% goat serum and goat anti-rabbit (1:400) (SC2012), by Santa Cruz
biotechnology and was allowed to act for 30 minutes[35]. The secondary antibody solution
was removed, the wells were washed 2-3 times, a drop of DAPI was added and
observations were made using Zeiss axiovert A1 Fluorescence microscope.
3.10 Immunofluorescence Analysis
The total number of cells was counted in DAPI channel. The number of cells
expressing TUJ1, GFAP, MBP2, HB9 and TH markers was counted separately in each
well. The average values and percentage differentiation of neural stem cells into neurons,
astrocytes, oligodendrocytes, motor neurons and dopamine producing neurons were
determined.
3.11 Statistical Analysis
All the data obtained from each experiment was analyzed statistically using sigma
plot, one-way ANOVA and student’s t-test in Microsoft Excel®. The variance between
data was considered significant for p< 0.05.
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Marker

Specificity

Primary
antibody
Beta III tubulin Neurons
Monoclonal
beta
III
tubulin
antibody
Glial fibrillary Astrocytes polyclonal
acidic protein
GFAP
antibody
Myelin
basic OligoMonoclonal
protein
dendrocytes MBP2
antibody
HB9
Motor
HB9 antibody
neurons
Tyrosine
Dopamine
Anti-TH
hydroxylase
producing
antibody
neurons

Host

Serum

Rabbit

Goat

Rabbit

Goat

Goat
rabbit

Rat

Goat

Goat anti rat

Goat

Donkey

Rabbit

Goat

Donkey antigoat
Goat
anti
rabbit

Table -I Summary of Antibodies used to stain various markers.
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Secondary
Antibody
Goat
anti
rabbit

anti

CHAPTER IV
RESULTS AND DISCUSSION

This chapter discusses the results from all the experiments outlined in Chapter-III.
There were two sets of heavy metal concentrations used throughout this study which are
indicated as higher concentrations (0.01-10 µM) and lower concentrations (0.01-1 nM).
We cultured the cells for 14 days within 3D collagen scaffolds, and quantified the
viability, neurite outgrowth and differentiation of NSCs at different time intervals and
compared to control cultures which did not receive any metal solution added to the
media.
4.1 Live/dead assay at higher concentrations
The survival of NSCs exposed to higher concentrations of metal ions is shown in
Figs. 4.1 and 4.2.From these results we found that on day-1, there was no statistical
difference between the control and the three metals at concentrations 0.01 µM, 0.1 µM
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and 1 µM. However, at 10 µM concentrations of three types of metals, there was a
statistically significant decrease in the cell survival compared to control. The percentage
of surviving cells in control was 83% and at 10 µM of cadmium, mercury and lead it was
77% (p = 0.039), 76% (p= 0.036) and 77% (p = 0.04) respectively. By day4, the survival
rate was ~81% within controls, but there was an overall dramatic decline in NSC survival
to less than 15% at all the higher concentrations independent of the metal type. These
results suggest that cadmium, lead and mercury concentrations between 0.01 µM and 10
µM are detrimental to neural stem cell survival. We further studied the cytotoxicities of
metal ions at concentrations lower than 0.01 µM. Similar cytotoxic effect has been
reported in case of cadmium by Culbreth et al., where they observed that the neural stem
cell viability decreased by 50% when exposed for6 h to 10 µM concentration, and similar
decline at 0.001 µM-100 µM concentrations when exposed for 24 h[24,25]. In another study
by Zychowicz et al., there was a significant decrease in the neural stem cell viability
between the concentration 0.06 µM and 1 µM after a 48 h exposure to methyl
mercury[27,26]. Their study contained a different pattern of growth factors and supplements
in their experiments. Our study was not supplied with any growth promoting factors.
Huang et al reported that lead is inhibiting the cell viability at concentrations 0.1 µM to
100 µM in floating neurospheres of neural stem cells at different time exposures[28].
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Figure 4.1 Percentage survival of NSCs at day-1 and day-4. The data shown reflects the
mean ± standard error (n=3/ case).Percentage of neural stem cells surviving in the 3D
cultures supplied with cadmium chloride (A), mercury chloride (B), or lead acetate (C).
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Figure 4.2 Immunofluorescence images showing live and dead cells at higher
concentrations on day-1 and day-4 in presence of cadmium (n=3/case, 40 magnification,
and scale bar = 50 µm). Images from Live/Dead assay in the presence of mercury and
lead are shown in Appendix A
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4.2 Live/ dead assay at lower metal ion concentrations:
The results from the NSC survival assays at lower metal ion concentrations are
shown in Figs.4.3 and 4.4.On day-7, there was no statistically significant difference in
cell survival between control and cadmium-supplied NSCs. Similar trends were noted in
the presence of mercury, except at 1nM concentration where a decrease of 12% in NSC
survival was noted compared to controls (p = 0.03). By day 7, lead had no significant
cytotoxic effect at 0.1 nM and 1 nM compared to controls. On day-14, a decrease in cell
viability with an increase in metal ion concentration was observed irrespective of the
metal type studied. Cadmium showed nearly similar rate of survival at all concentrations
(0.0 1nM, 0.1 nM, 1 nM), with an overall significant decrease compared to controls. In
controls, the percentage of surviving cells was ~75% and the average survival rate in 0.01
nM, 0.1 nM and 1 nM was 42% (p = 0.0002), 36% (p = 0.00006) and 37% (p =
0.000015), respectively. Similarly, there was a significant decrease in the cell survival
with increasing mercury concentration. The cell survival declined to 27% at 1 nM, 34%
at 0.1 nM and 45% at 0.01 nM. Similar trends were noted in lead supplemented cultures
with increasing ion concentration. From these results, we conclude that: (a) the toxic
effects of these heavy metals increased with an increase in exposure time. On day-7 the
cell survival at 0.01 nM concentrations of all metals were similar to controls, but they
decreased significantly by day-14. (b) The cell viability decreased as the concentration of
heavy metal increased. At 1 nM concentration, all metals induced a majority of cell
death. Not much information is available in literature about the toxic effects of cadmium,
mercury and lead at concentrations lower than 1 µM.
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Figure 4.3 Percentage of neural stem cells surviving on day-7 and day-14 at lower
concentrations. The data shown reflects the mean ± standard error (n=3/ case). Percentage
survival of neural stem cells in presence of cadmium (A), mercury (B), and lead(C).
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Figure 4.4 Immunofluorescence images showing live and dead cells at lower
concentrations on day-7 and day-14 in presence of cadmium (n=3/case, 40
magnification, scale bar = 50 µm). Images for Live/ Dead assay in presence of mercury
and lead are shown in Appendix A.

4.3 Neurite outgrowth at higher concentrations
The neural stem cells were cultured for day-1 and day-4 under given conditions
and stained with phalloidin. It extensively stained for the actin filaments present in the
cells which allowed us to measure the cellular outgrowth using Image-J. The
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corresponding data is shown in Figs. 4.5 and 4.6. On day-1, no statistically significant
difference in neurite outgrowth was noted between controls and metal ion receiving
cultures. Although significant increase in the neurite outgrowth was observed in control
cultures by day 4 (p< 0.001 vs. day 1), no measurable neurite outgrowth was observed in
any of the heavy metal treated cell cultures on day 4. This shows that at higher
concentrations, heavy metal ions (0.01 µM-10 µM) are not only contributing to cell death
but also arrest the neurite outgrowth of the surviving ones. However, the molecular
mechanism by which this inhibition of neurite outgrowth is modulated needs further
investigation. In the previous studies it has been noted that concentrations between 0.001
µM-100 µM of cadmium caused necrosis of neural cells at higher concentrations and
induced apoptosis at lower concentrations, which eventually made the neurite extensions
to disappear over time[24,25].The methyl mercury was also observed to cause decrease in
neurite extensions at 0.1 µM– 10 µM in previous studies [27]. The metal exposure in their
study was done after culturing the neural stem cells for 24 hours. Lead is reported to
cause a retraction of cell outgrowths and change in morphology of the cells to more
spherical form[28,30].
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Figure 4.5 Average neurite outgrowth on day-1 and day-4. The data shown above is
mean ± standard error (n=3/case). Neurite outgrowth in cadmium (A), mercury (B) and
lead (C) supplemented cell cultures.
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(A)

(B)

Figure 4.6 Immunofluorescence images showing neurite outgrowth in presence of
cadmium on day-1(A) and day-4 (B), at higher ion concentrations (n=3/case, 40
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magnification, scale bar = 50 µm).Images for neurite growth in the presence of mercury
and lead are shown in Appendix B.
4.4 Neurite outgrowth at lower concentrations
The neural stem cells were cultured in 3D collagen scaffolds for days -1, 4, 7, 10
and 14 in separate well plates. At the end of respective culture periods, the wells were
stained with Alexa488® phalloidin and images were taken. The neurite outgrowth at each
concentration of three metals was quantified using NIH Image-J software. The average
values in each case were compared to controls. The results are shown in Figs. 4.7 and
4.8.On day-1 there was no statistically significant difference in neurite outgrowth
between control and at all the metal ion concentrations tested. The neurite outgrowth in
the presence of 0.01 nM concentration cadmium is similar to that in controls at all the
time points. At 0.1 nM concentration, cadmium showed neurite growth similar to that in
control on day-1, but neurite outgrowth significantly decreased by day-4. Surprisingly,
from day-7 till day 14, the neurite outgrowth was statistically similar to controls. At 1 nM
cadmium ion concentration, the neurite growth was suppressed during the entire culture
period. However, on day 14 the neurite growth started to increase, albeit lower than that
in control. This suggests that NSCs may be undergoing some intracellular compensatory
mechanism to overcome the toxic effects over a period of time, which needs further
investigation.
Compared to controls, mercury at 0.01 nM had no effect on the neurite growth of
neural stem cells on any day of observation. At 0.1 nM mercury ion concentration,
neurite outgrowth decreased by 48% on day 1 (p = 0.0002) and by 47% (p= 0.0053) on
day4. However, from day-7 to day-14, the pace of neurite outgrowth increased and was
37

similar to that noted in cadmium supplemented cultures at same concentration and time
points.
Lead induced a decrease in neurite length as the concentration increased, even at
lower concentrations. In 0.01 nM cadmium and mercury-supplemented cultures the
growth patterns showed similarity with control on day-4, but there was a decrease at
higher concentrations. Lead showed similar effect as of day-1. An interesting pattern of
neurite growth was observed in day-7 results. The lower concentrations 0.01 and 0.1 nM
of all metals showed no significant difference compared to control, whereas all the metals
at 1 nM induced lower outgrowths. On day-10 and day-14, neurite outgrowths at all
cadmium concentrations showed no statistically significant difference compared to
control. Mercury and lead showed a difference only at 1 nM. From these results, it is
evident that initially cadmium, mercury and lead are inhibiting the neurite growth to
some extent at concentrations 0.1and 1 nM. But there was regrowth of neurites at 0.1 nM,
eventually nearing control values. However, 1 nM mercury concentration significantly
affected the neurite growth on all the days of exposure.
Lead exhibited higher toxicity than the other two metals, with regard to NSC
cultures. Even on day-1, it affected the neurite growth at all the concentrations tested.
From day4 to day-14, neurite extensions were not statistically different within0.01 nM
and 0.1 nM supplemented cultures, compared to controls. The cell cultures supplied with
1 nM lead experienced significant decline in neurite growth at all the time intervals of
exposure. The average neurite lengths on day-1, 4,7,10 and 14 were measured to be 15.05
µm, 22.74 µm,29.26 µm, 37.16 µm and49.1 µm respectively in controls, and8.13 µm,
12.97 µm, 13.45 µm, 13.7 µm and16.71 µm, respectively, at 1 nM dosage.
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From the above results it could be deduced that 0.01 nM cadmium and mercury
were not significantly affecting the neurite growth. At 0.1 nM concentration of these two
metals, decrease in neurite growth was observed initially from days1-4, after which they
were restored to the values noted in controls. The similar observation was made in case of
0.01 nM and 0.1 nM of lead. All the three metals are hindering the intercellular
communication and development of neural stem cells at 1nM.In case of cell cultures with
heavy metal ions in media,

the degree of toxicity was in the order:

lead>mercury>cadmium.

39

Figure 4.7 Average neurite growth at different metal ion concentrations and culture
duration. The data shown reflects the mean ± standard error (n=3/case).Average neurite
outgrowth in the presence of cadmium (A), mercury (B), and lead (C), over the 14 day
culture period.
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Figure 4.8 Immunofluorescence images showing neurite outgrowth at lower metal ion
concentrations on day-14. (n=3/case, 40 magnification, scale bar = 50 µm). Images for
day-1 and day-7 are listed in Appendix B.
4.5 Quantification of differentiated neural cells on day-7
The neural stem cells were cultured for 7- days and stained for the markers TUJ1,
GFAP and MBP2. The differentiation at all conditions is shown in Figs.4.9 and 4.10. The
expression of TUJ1 marker in cadmium was not statistically different from control at 0.01
and 0.1 nM, but it significantly decreased at 1 nM. Similar patterns were noted with the
expression of GFAP and MBP at 1 nM, but there was no statistically significant
difference between expression level of GFAP and MBP at 0.01 and 0.1 nM. In mercurysupplemented cultures, TUJ1 expression was significantly affected at all concentrations,
and GFAP and MBP were affected only at 1 nM. Lead also showed similar behavior as
that of mercury. All the three metal ions decreased the expression of TUJ1, GFAP and
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MBP at 1 nM, compared to controls. On day-7 cadmium was noted to be ineffective at
0.01 and 1 nM. Mercury and lead did not affect the GFAP and MBP until their
concentration reached 1 nM.

Figure 4.9 Percentage of NSCs differentiating into neural and glial lineagesby day-7. The
data shown reflects the mean ± standard error (n=3/case).Percentage expression of TUJ1,
GFAP and MBP in presence of cadmium(A), mercury(B), and lead(C).
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Figure 4.10 Immunofluorescence images showing differentiation of NSCs in presence of
cadmium on day 7 (n=3/each case, 40× objective, scale bar = 50 µm). Images for
differentiation in presence of mercury and lead are listed in Appendix C.
4.6 Quantification of differentiated neural cells on day-14
The neural stem cells were cultured for 14 days and stained for the markers TUJ1,
GFAP and MBP2. The percentage differentiation is shown in Fig.4.11and fluorescence
images in Fig. 4.12.Compared to that in controls, cadmium did not affect the expression
of TUJ1, GFAP and MBP at 0.01 nM. At 0.1 nM, the differentiation of neurons and
oligodendrocytes from neural stem cells was found to be significantly less than control.
Cadmium did not affect the differentiation of astrocytes at any concentration. Mercury
addition resulted in behavior similar to cadmium at 0.01 nM, by not showing any
difference in expression of TUJ1, GFAP and MBP when compared to control. At 0.1 nM,
it inhibited the differentiation of astrocytes and neurons, but had no effect on
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oligodendrocytes differentiation. At 1nM mercury addition, the differentiation into all the
three lineages was significantly reduced. In controls, the average percentage of TUJ1,
GFAP and MBP expression was 57%, 8% and 6% respectively, and it reduced to 26%,
3% and 2% respectively, at 1nM. Lead was toxic than other two metals as it induced a
significant decrease in differentiation even at0.01 nM. The differentiation of neurons
decreased as the concentration of lead increased. Similar pattern was observed in case of
GFAP expression. The oligodendrocytes differentiation went from 2% at 0.01 nM to 1%
at 0.1 nM and to 0% 1 nM.
Buzanska et al. reported that after culturing the neural stem cells for 7 and 14
days, spontaneous differentiation in presence of cadmium and mercury for 48 hours
induced a decrease in the expression of neuronal, astrocytes and oligodendrocytes cell
specific markers[26]. Zychowicz et al. reported a considerable decrease in the expression
of neural and glial cell markers at concentrations 0.05 µM– 10 µM after 48 h and 72 h
exposure[27]. Lead has been noted to cause a decrease in differentiation of NSCs at
concentrations between 0.1-100 µM, in floating neurospheres in a 2D model[28, 30].Not
much information is available in literature at concentrations lower than 10µM for any of
the metals studied here.
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Figure 4.11 Percentage differentiations of neural stem cells on day 14 in presence of (A)
cadmium, (B) mercury, (C) lead. The data shown reflects the mean ± standard error
(n=3).
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Figure 4.12 Immunofluorescence images showing differentiation of neural stem cells in
presence of cadmium on day-14 (n=3/case, 40 magnification, scale bar = 50 µm).Images
for differentiation of NSCs in the presence of mercury and lead are listed in Appendix C.
4.7. Differentiation of neural stem cells into motor neurons
NSCs were cultured for 7 or14 days and stained for HB9 marker. HB9 is specific
for identifying the presence of motor neurons in the neural cell population. The results for
this experiment is shown in Figs.4.13 and 4.14. On day 7, at 0.01 nM concentration for
all metals tested, there was no significant effect on NSC differentiation compared to
controls. NSC differentiation into motor neuron significantly decreased at 0.1 nM
concentration of these metals in general (day 7).At 1 nM concentration, no staining for
HB9 marker was noted.
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When 0.01 nM concentration of cadmium or mercury was supplemented to NSC
cultures, no significant difference in motor neuron differentiation was noted compared to
control. However, there was a significant decrease in lead supplemented cultures, even at
concentrations as low as 0.01 nM. At 0.1 nM and 1 nM dosages, all the three metal ions
significantly suppressed NSC differentiation into motor neuron lineage, compared to
controls. However, motor neuron formation at day 14 is significantly higher than that at
day 7, for each of the metals tested at 0.1 and 1 nM dosages. It could be concluded that
the decrease in motor neuron differentiation is dependent on increase in the concentration
of heavy metal ions. These results are comparable to previous literature where they
reported a decrease in formation of motor neurons in exposed zebra fish embryo cultures
at concentrations 0.1-100 µM of cadmium[29]. Exposure to mercury at 1-10 µM of organic
and inorganic mercury has been reported in many studies to cause in malformations of
motor neurons[26]. Kermani et al. reported a decrease in differentiation of motor neurons
at similar concentrations of lead in case of bone marrow mesenchymal derived NSCs[30].
It is also noted in their study that the differentiation is affected by the source of stem cells
and other culture conditions[30].
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Figure 4.13 Differentiation of NSCs into motor neurons on day 7 and day 14 in presence
of various concentrations of cadmium (A), mercury(B), and lead(C).The data shown
reflects the mean ± standard error (n=3/case).
4.8. Differentiation of NSCsinto dopaminergic neurons
NSCs were cultured for 7 or14 days and stained for Tyrosine Hydroxylase (TH)
marker. TH is specific for identifying the presence of dopaminergic neurons in the neural
cell population. The results for this experiment is shown in Fig.4.14 and 4.15. On day 7,
at 0.01 nM concentration for all metals tested, there was no significant effect on NSC
differentiation compared to controls. NSC differentiation into dopaminergic neuron
significantly decreased at 0.1 nM and 1 nM concentration of these metals in general, at
all types of tested metals, on day-7 and day 14, compared to control. However there was
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an increase in dopaminergic neuron marker from day-7 to day-14 in case of all metals.
Previous studies have shown a decrease in dopamine formation, release or
neurotransmission of dopamine in presence of these metals, but there is not much
information available addressing the effects of various metal ions and their
concentrations on NSC differentiation[4,5, 6,7,9].

Figure 4.14 Percentage differentiation of NSCs into dopaminergic neurons in presence of
cadmium (A), mercury (B), and lead (C). Data represents mean ± standard error of the
results, with n = 3/case.
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Figure 4.15 Immunofluorescence images showing differentiation of NSCs into motor
neurons and dopaminergic neurons in presence of cadmium on day-7 and day-14
(n=3/case, 40 magnification, scale bar = 50 µm). Images for differnetiation of NSCs in
presence of mercury and lead are listed in Appendix C.
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CHAPTER V
CONCLUSIONS AND FUTURE RECOMMENDATIONS

In this work, we have studied the toxic effects of the most commonly found heavy
metal pollutants-cadmium, mercury and lead, on the neural stem cell proliferation,
viability, differentiation into various neural and glial lineages, and neurite outgrowth. The
metal concentrations ranged from 0.01 nM to 10 µM, with cultures no supplements acting
as controls. We performed the cultures for 14 days, with experimental outcomes
measured at various intermediate time points. Results were compared intra-group for
each metal, and inter-group across the metals, and finally with regard to controls.
5.1 Conclusions
 Culturing NSCs within 3D collagen scaffolds might be more physiological
representation of in vivo pathology, compared to conventional 2D cultures.
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 When cadmium, mercury and lead were compared to each other the order of toxicity
was found to be Lead > Mercury > Cadmium with regard to viability, differentiation
rate and neurite outgrowth of the neural stem cells.
 The cytotoxic effects of these metals on NSC cultures increased with an increase in
concentration and time of exposure.
 By day 4, cell death was significant at concentrations of 0.01 µM, 0.1 µM, 1 µM and
10 µM, independent of the type of metal.
 Similarly, significant reduction in neurite growth at these higher concentrations was
noted by day 4. This could either be due to significant release of inflammatory
markers by NSCs into the surrounding media in response to heavy metal ion
exposure, or due to retraction of neurite in surviving neurons due to hitherto unknown
intracellular signaling pathways. Further studies are required to understand this
phenomenon in greater detail.
 Investigations at concentrations lower than 0.01 µM helped us pinpoint the lowest
concentration which compromises NSC phenotype.
 In general, heavy metal exposure at concentrations ranging from 0.01 nM–10 µM did
not induce any significant toxic effects in NSCs within the first 24 h, except for lead.
 At 0.1 nM dosage, cadmium and mercury induced slightly different behavior in
NSCs. Although neurite outgrowth was affected during the first 4 days of exposure, it
recovered from day-7 and reached values noted within respective controls. This
suggests that there could be a compensatory mechanism occurring to overcome the
inhibition by metals or some other factor involved which needs to be further studied.

52

 Dramatic changes in NSC behavior and phenotype were noted at concentrations
higher than 0.1 nM, irrespective of the type of metal, and 1nMinducedthe toxic
effects which were clearly evident in all experiments.
 The differentiation of NSCs into neural and glial lineages was significantly reduced at
1nM concentration of cadmium, mercury and lead. The expression of MBP declined
to 0% in 0.1 nM lead exposed cultures, suggesting that lead exposure might be
inhibiting myelin production important for insulates neural cells to help proper signal
conduction of neural communication.
 The overall differentiation of NSCs into neurons and glial cells decreased with an
increase in heavy metal concentration and time of exposure. But, the opposite effect
was observed within the types of neural cells differentiating at that time. The
percentage of motor neurons increased with time of exposure, but less in quantity
than controls. Motor neuron formation decreased with an increase in metal ion
concentration.
 Similarly the expression of dopaminergic marker increased with time but decreased
with an increase in concentration. The expression of TH was higher than HB9 in all
cases which suggests that the motor neurons are being the sensitive targets.
 The comparison between the average mean blood concentrations provided by ATSDR
as safe concentration and the tested concentration which was detrimental for NSC
survival and differentiation is shown in table II.
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Type of metal

National mean safe blood Concentration found to be
concentrations provided by detrimental for NSCs
ATSDR

Cadmium

0.038µg/dL (3.4nM)

0.1 nM

Mercury

5 µg/dL (0.24 µM)

0.1 nM

Lead

5µg/dL (0.25 µM)

0.01 nM

Table –II Comparison of the tested concentrations with national geometric mean blood
levels[4,5,6]

5.2 Future Recommendations
 Study the toxic effects of metal ions at the molecular level; investigate the
biochemical changes within the cells and extracellular matrix.
 Determine the metal ion effects at the genetic level, which could help understand
the cause-effect relationship between genetic level changes and cellular behavior
in affected subjects.
 Investigate the effect of heavy metals on neurodegenerative diseases like
Parkinson’s and Alzheimer’s disease.
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APPENDIX A
Figure A-1 Immunofluorescence images showing live and dead cells in presence of
mercury at high concentrations on day-1 and day- 4 ( n=3/ each concentration,
40×objective, scale bar = 50 µm).
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Figure A-2 Immunofluorescence images showing live and dead cells in presence of lead
at high concentrations on day-1 and day- 4 ( n=3/ each concentration, 40×objective, scale
bar = 50 µm).
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Figure A-3 Immunofluorescence images showing live and dead cells in presence of
mercury at low concentrations on day-7 and day-14 ( n=3/ each concentration,
40×objective, scale bar = 50 µm).
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Figure A-4 Immunofluorescence images showing live and dead cells in presence of lead
at low concentrations on day-7 and day-14 ( n=3/ each concentration, 40×objective, scale
bar = 50 µm).
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APPENDIX B

Figure B-1 Immunofluorescence images showing neurite growth on day-1 at lower
concentrations (n=3/ each concentration, 40×objective, scale bar = 50 µm).
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Figure B-2 Immunofluorescence images showing neurite growth on day-7 at lower
concentrations (n=3/ each concentration, 40×objective, scale bar = 50 µm).
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APPENDIX C

Figure C-1 Immunofluorescence images showing differentiation of NSCs in presence of
mercury ions on day-7
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Figure C-2 Immunofluorescence images showing differentiation of NSCs in presence of
lead ions on day-7.
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Figure C-3 Immunofluorescence images showing differentiation of NSCs in presence of
mercury ions on day-14
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Figure C-4 Immunofluorescence images showing differentiation of NSCs in presence of
lead ions on day-14.
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Figure C-5 Immunofluorescence images showing differentiation of NSCs into motor
neurons and dopaminergic neurons in presence of mercury ions on day-7 and day-14.
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Figure C-6 Immunofluorescence images showing differentiation of NSCs into motor and
dopaminergic neurons in presence of lead ions on day-7 and day-14.
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